Firms
Kerna Ventures
Kerna Ventures is an early-stage venture capital firm investing in advanced therapeutic platform technologies, from seed through Series B. Its focus includes genome engineering, cell reprogramming, computational biology and drug delivery. Its neuroscience investments include RNA delivery across the blood-brain barrier, cell therapies for Parkinson’s disease and gene therapy for focal refractory epilepsy. The firm was founded in 2022.
- Founded
- 2022
- Type
- Venture capital
Funds0
No funds on record yet.
Team
Operations and support
Co-investing
Ada Ventures
Aerska$21M · 2025-10-01
BlueYard Capital
- Aerska$21M · 2025-10-01
Norrsken VC
- Aerska$21M · 2025-10-01
PsyMed Ventures- Aerska$21M · 2025-10-01
Saras Capital- Aerska$21M · 2025-10-01
Speedinvest- Aerska$21M · 2025-10-01
Investments
| $21M2025-10-01 | Aerska | Speedinvest, BACKED VC, age1, PsyMed Ventures, BlueYard Capital, Lingotto, Norrsken VC, Ada Ventures, Saras Capital, Kerna Ventures |
| $—Unknown date |  Cavalry Biosciences | Kerna Ventures |
| $—Unknown date |  Axent Biosciences | Kerna Ventures |
| $—Unknown date |  Focalis Bio | Kerna Ventures |